Diversified Trust Co bought a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 16,305 shares of the company’s stock, valued at approximately $236,000.
Several other large investors have also recently made changes to their positions in the business. Nomura Asset Management Co. Ltd. raised its holdings in Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after acquiring an additional 1,220 shares during the last quarter. GAMMA Investing LLC raised its holdings in Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock worth $37,000 after acquiring an additional 1,765 shares during the last quarter. Parkside Financial Bank & Trust raised its holdings in Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after acquiring an additional 1,040 shares during the last quarter. AlphaQuest LLC raised its holdings in Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock worth $66,000 after acquiring an additional 2,012 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its holdings in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock worth $91,000 after acquiring an additional 6,090 shares during the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.
Pediatrix Medical Group Trading Down 0.1%
Shares of MD stock opened at $14.33 on Wednesday. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The firm has a fifty day moving average price of $13.80 and a 200-day moving average price of $13.91. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.81 and a quick ratio of 1.81. The company has a market cap of $1.23 billion, a price-to-earnings ratio of -14.19, a PEG ratio of 0.97 and a beta of 1.25.
Analyst Ratings Changes
A number of research firms have commented on MD. Truist Financial cut their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 11th. Macquarie lifted their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Thursday, May 8th. Finally, UBS Group cut their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating for the company in a research report on Monday, May 12th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $16.67.
View Our Latest Stock Analysis on MD
Pediatrix Medical Group Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Further Reading
- Five stocks we like better than Pediatrix Medical Group
- Why is the Ex-Dividend Date Significant to Investors?
- Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside
- Trading Halts Explained
- Breakout Alert: Disney Stock Hits Multi-Year High
- Top Biotech Stocks: Exploring Innovation Opportunities
- Forget IBM: Accenture’s AI Momentum Is Your Next Buy
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.